Eligibility check
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Step 1 of 5
Where are you located?
We confirm your state so we only show studies you can actually reach.
Your answers help match you to studies and connect you with the research team. They're handled per our Privacy Policy.